MTHFR C677T and A1298C Polymorphisms were associated with bladder cancer risk and disease progression: A meta-analysis

DNA and Cell Biology

Volumn 32, Issue 5, 2013, Pages 260-267

  You, Wu ^a   Li, Zuo ^b,c   Jing, Chen ^b   Qian Wei, Xing ^a   Yu Ping, Zhang ^a   Weng Guang, Li ^a   Hua Lei, Li ^a  

^a NANTONG UNIVERSITY   (China)

^b THE AFFILIATED CHANGZHOU NO 2 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

AFRICA; ARTICLE; ASIAN; BLADDER CANCER; CANCER GROWTH; CANCER RISK; EUROPE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW;

ALANINE; AMINO ACID SUBSTITUTION; CARCINOMA; CASE-CONTROL STUDIES; CYSTEINE; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; THREONINE; URINARY BLADDER NEOPLASMS;

EID: 84877590697     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2012.1931     Document Type: Article

References (40)

1. Beebe-Dimmer, J.L., Iyer, P.T., Nriagu, J.O., Keele, G.R., Mehta, S., Meliker, J.R., Lange, E.M., Schwartz, A.G., Zuhlke, K.A., Schottenfeld, D., and Cooney, K.A. (2012). Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study. Environ Health 11, 43.
2. Cai, D.W., Liu, X.F., Bu, R.G., Chen, X.N., Ning, L., Cheng, Y., and Wu, B. (2009). Genetic polymorphisms of MTHFR and aberrant promoter hypermethylation of the RASSF1A gene in bladder cancer risk in a Chinese population. J Int Med Res 37, 1882-1889.
3. Chung, C.J., Pu, Y.S., Su, C.T., Chen, H.W., Huang, Y.K., Shiue, H.S., and Hsueh, Y.M. (2010). Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma. Cancer Causes Control 21, 1605-1613.
4. DerSimonian, R., and Laird, N. (1986). Meta-analysis in clinical trials. Control Clin Trials 7, 177-188.
5. Dong, X., Wu, J., Liang, P., Li, J., Yuan, L., and Liu, X. (2010). Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer: a meta-analysis. Arch Med Res 41, 125-133.
6. Egger, M., Davey Smith, G., Schneider, M., and Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634.
7. Freedman, N.D., Silverman, D.T., Hollenbeck, A.R., Schatzkin, A., and Abnet, C.C. (2011). Association between smoking and risk of bladder cancer among men and women. JAMA 306, 737-745.
8. Frosst, P., Blom HJBlom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G., Boers, G.J., den Heijer, M., Kluijtmans, L.A., and van den Heuvel, L.P. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111-113.
9. Garcia-Closas, R., Garcia-Closas, M., Kogevinas, M., Malats, N., Silverman, D., Serra, C., Tardon, A., Carrato, A., Castano-Vinyals, G., Dosemeci, M., Moore, L., Rothman, N., and Sinha, R. (2007). Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. Eur J Cancer 43, 1731-1740.
10. Goyette, P., Pai, A., Milos, R., Frosst, P., Tran, P., Chen, Z., Chan, M., and Rozen, R. (1998). Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 9, 652-656.
11. Gueant, J.L., Chabi, N.W., Gueant-Rodriguez, R.M., Mutchinick, O.M., Debard, R., Payet, C., Lu, X., Villaume, C., Bronowicki, J.P., Quadros, E.V., Sanni, A., Amouzou, E., Xia, B., Chen, M., Anello, G., Bosco, P., Romano, C., Arrieta, H.R., Sanchez, B.E., Romano, A., Herbeth, B., Anwar, W., and Namour, F. (2007). Environmental influence on the worldwide prevalence of a 776C->G variant in the transcobalamin gene (TCN2). J Med Genet 44, 363-367.
12. Helfenstein, T., Fonseca, F.A., Relvas, W.G., Santos, A.O., Dabela, M.L., Matheus, S.C., D'Almeida, V., Tufik, S., Souza, F.G., Rodrigues, P.R., Taglieri, R., Sousa, E.F., and Izar, M.C. (2005). Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects. Clin Chim Acta 355, 165-172.
13. Hoover, R., and Cole, P. (1971). Population trends in cigarette smoking and bladder cancer. Am J Epidemiol 94, 409-418.
14. Izmirli,M., Inandiklioglu,N., Abat,D., Alptekin,D., Demirhan,O., Tansug, Z., Bayazit, Y. (2011). MTHFR gene polymorphisms in bladder cancer in the Turkish population. Asian Pac J Cancer Prev 12, 1833-1835.
15. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., and Forman, D. (2011). Global cancer statistics. CA Cancer J Clin 61, 69-90.
16. Jemal, A., Siegel, R., Xu, J., and Ward, E. (2010). Cancer statistics, 2010. CA Cancer J Clin 60, 277-300.
17. Karagas, M.R., Park, S., Nelson, H.H., Andrew, A.S., Mott, L., Schned, A., and Kelsey, K.T. (2005). Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study. Int J Hyg Environ Health 208, 321-327.
18. Kimura, F., Florl, A.R., Steinhoff, C., Golka, K., Willers, R., Seifert, H.H., and Schulz, W.A. (2001). Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladder. Mutat Res 458, 49-54.
19. Lin, J., Spitz, M.R., Wang, Y., Schabath, M.B., Gorlov, I.P., Hernandez, L.M., Pillow, P.C., Grossman, H.B., and Wu, X. (2004). Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis 25, 1639-1647.
20. Lwin, H., Yokoyama, T., Date, C., Yoshiike, N., Kokubo, Y., and Tanaka, H. (2002). Are the associations between life-style related factors and plasma total homocysteine concentration different according to polymorphism of 5,10-methylenetetrahydrofolate reductase gene (C677T MTHFR)? A crosssectional study in a Japanese rural population. J Epidemiol 12, 126-135.
21. Mannino, D.M., Mulinare, J., Ford, E.S., and Schwartz, J. (2003). Tobacco smoke exposure and decreased serum and red blood cell folate levels: data from the Third National Health and Nutrition Examination Survey. Nicotine Tob Res 5, 357-362.
22. Mantel, N., and Haenszel, W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22, 719-748.
23. Moore, L.E., Malats, N, ., Rothman, N., Real, F.X., Kogevinas, M., Karami, S., Garcia-Closas, R., Silverman, D., Chanock, S., Welch, R., Tardo n, A., Serra, C., Carrato, A., Dosemeci, M., and Garcia-Closas, M. (2007). Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer 120, 2452-2458.
24. Moore, L.E., Wiencke, J.K., Bates, M.N., Zheng, S., Rey, O.A., and Smith, A.H. (2004). Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina. Cancer Lett 211, 199-207.
25. Querhani, S., Rouissi, K., Marrakchi, R., Ben Slama, M.R., Sfaxi, M., Chebil, M., and ElGaaied, A.B. (2009). Combined effect of NAT2, MTR and MTHFR genotypes and tobacco on bladder cancer susceptibility in Tunisian population. Cancer Detect Prev 32, 395-402.
26. Rady, P.L., Szucs, S., Grady, J., Hudnall, S.D., Kellner, L.H., Nitowsky, H., Tyring, S.K., and Matalon, R.K. (2002). Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 107, 162-168.
27. Rouissi, K., Ouerhani, S., Oliveira, E., Marrakchi, R., Cherni, L., Ben Othman, F., Ben Slama, M.R., Sfaxi, M., Ayed, M., Chebil, M., Amorim, A., Prata, M.J., and Benammar Elgaaied, A. (2009). Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population. Cancer Genet Cytogenet 195, 43-53.
28. Rouissi, K., Stambouli, N., Marrakchi, R., Slama, M.R., Cherif, M., Sfaxi, M., Chebil, M., Elgaaied, A.B., and Ouerhani, S. (2011). Smoking and polymorphisms in folate metabolizing genes and their effects on the histological stage and grade for bladder tumors. Bull Cancer 98, E1-E10.
29. Safarinejad, M.R., Shafiei, N., and Safarinejad, S. (2011). Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men. Med Oncol 28, S398-S412.
30. Sanyal, S., Festa, F., Sakano, S., Zhang, Z., Steineck, G., Norming, U., Wijkstro?m, H., Larsson, P., Kumar, R., and Hemminki, K. (2004). Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25, 729-734.
31. Sanyal, S., Ryk, C., De Verdier, P.J., Steineck, G., Larsson, P., Onelov, E., Hemminki, K., and Kumar, R. (2007). Polymorphisms in NQO1 and the clinical course of urinary bladder neoplasms. Scand J Urol Nephrol 41, 182-190.
32. Saw, S.M., Yuan, J.M., Ong, C.N., Arakawa, K., Lee, H.P., Coetzee, G.A., and Yu, M.C. (2001). Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore. Am J Clin Nutr 73, 232-239.
33. Strope, S.A., and Montie, J.E. (2008). The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation. J Urol 180, 31-37.
34. Sun, J., Xu, Y., Zhu, Y., and Lu, H. (2004). Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Res Clin Pract 64, 185-190.
35. Tungtrongchitr, R., Pongpaew, P., Soonthornruengyot, M., Viroonudomphol, D., Vudhivai, N., Tungtrongchitr, A., Phonrat, B., Pooudong, S., and Schelp, F.P. (2003). Relationship of tobacco smoking with serum vitamin B12, folic acid and haematological indices in healthy adults. Public Health Nutr 6, 675-681.
36. van der Put, N.M., Gabree?ls, F., Stevens, E.M., Smeitink, J.A., Trijbels, F.J., Eskes, T.K., van den Heuvel, L.P., and Blom, H.J. (1998). A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neuraltube defects? Am J Hum Genet 62, 1044-1051.
37. Wang, M., Zhu, H., Fu, G., Wang, M., Zhang, Z., Lu, Q., Wang, S., and Zhang, Z. (2009). Polymorphisms of methylenetetrahydrofolate reductase and methionine synthase genes and bladder cancer risk: a case-control study with meta-analysis. Clin Exp Med 9, 9-19.
38. Weisberg, I., Tran, P., Christensen, B., Sibani, S., and Rozen, R. (1998). A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64, 169-172.
39. Wynder, E.L., and Goldsmith, R. (1977). The epidemiology of bladder cancer: a second look. Cancer 40, 1246-1268.
40. Zhong, J.H., You, X.M., Gong, W.F., Ma, L., Zhang, Y., Mo, Q.G., Wu, L.C., Xiao, J., and Li, L.Q. (2012). Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis. PLoS One 7, e32159.